269 related articles for article (PubMed ID: 23770853)
1. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis.
Lu X; Mazur SJ; Lin T; Appella E; Xu Y
Oncogene; 2014 May; 33(20):2655-64. PubMed ID: 23770853
[TBL] [Abstract][Full Text] [Related]
2. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
3. Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog.
Schreiber C; Kuch V; Umansky V; Sleeman JP
PLoS One; 2013; 8(2):e57465. PubMed ID: 23468991
[TBL] [Abstract][Full Text] [Related]
4. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
[TBL] [Abstract][Full Text] [Related]
5. NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro.
Simmons MJ; Serra R; Hermance N; Kelliher MA
Breast Cancer Res; 2012 Sep; 14(5):R126. PubMed ID: 22992387
[TBL] [Abstract][Full Text] [Related]
6. A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis.
Wang W; Meng Y; Dong B; Dong J; Ittmann MM; Creighton CJ; Lu Y; Zhang H; Shen T; Wang J; Rowley DR; Li Y; Chen F; Moore DD; Yang F
Neoplasia; 2017 May; 19(5):421-428. PubMed ID: 28433771
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
8. Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers.
Siu MK; Wong ES; Kong DS; Chan HY; Jiang L; Wong OG; Lam EW; Chan KK; Ngan HY; Le XF; Cheung AN
Oncogene; 2013 Jul; 32(30):3500-9. PubMed ID: 22945654
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
10. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human.
Hart AH; Hartley L; Ibrahim M; Robb L
Dev Dyn; 2004 May; 230(1):187-98. PubMed ID: 15108323
[TBL] [Abstract][Full Text] [Related]
11. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells.
Han J; Zhang F; Yu M; Zhao P; Ji W; Zhang H; Wu B; Wang Y; Niu R
Cancer Lett; 2012 Aug; 321(1):80-8. PubMed ID: 22381696
[TBL] [Abstract][Full Text] [Related]
13. Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.
Chen H; Lee JS; Liang X; Zhang H; Zhu T; Zhang Z; Taylor ME; Zahnow C; Feigenbaum L; Rein A; Sukumar S
Cancer Res; 2008 May; 68(10):3637-44. PubMed ID: 18463397
[TBL] [Abstract][Full Text] [Related]
14. ATF3-Induced Mammary Tumors Exhibit Molecular Features of Human Basal-Like Breast Cancer.
Yan L; Gaddis S; Coletta LD; Repass J; Powell KL; Simper MS; Chen Y; Byrom M; Zhong Y; Lin K; Liu B; Lu Y; Shen J; MacLeod MC
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652981
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Six1 homeobox gene in normal mammary gland morphogenesis.
Coletta RD; McCoy EL; Burns V; Kawakami K; McManaman JL; Wysolmerski JJ; Ford HL
BMC Dev Biol; 2010 Jan; 10():4. PubMed ID: 20074369
[TBL] [Abstract][Full Text] [Related]
16. GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.
Kuwahara K; Yamamoto-Ibusuki M; Zhang Z; Phimsen S; Gondo N; Yamashita H; Takeo T; Nakagata N; Yamashita D; Fukushima Y; Yamamoto Y; Iwata H; Saya H; Kondo E; Matsuo K; Takeya M; Iwase H; Sakaguchi N
Cancer Sci; 2016 Apr; 107(4):469-77. PubMed ID: 26749495
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y
Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551
[TBL] [Abstract][Full Text] [Related]
18. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
[TBL] [Abstract][Full Text] [Related]
19. Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells.
Kim J; Liu Y; Qiu M; Xu Y
Oncogene; 2016 Mar; 35(10):1334-40. PubMed ID: 26073077
[TBL] [Abstract][Full Text] [Related]
20. Tbx3 isoforms are involved in pluripotency maintaining through distinct regulation of Nanog transcriptional activity.
Zhao D; Wu Y; Chen K
Biochem Biophys Res Commun; 2014 Feb; 444(3):411-4. PubMed ID: 24472544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]